Illumina, Inc.Long
ILMN Bullish Comeback
On the 12 month timeframe, or yearly supercycle, ILMN seems to be consolidating enough these first 3 months into 2024 to ultimately flip to the upside with maximum bull force. The company has a solid catalyst with AI facilitating the end goal of a super biopharma product that perhaps all humanity may have to rely on: a panacea. This panacea may come in the form of a machine that prompts the users exactly what symptoms they have, and produce a medicine that cures said symptoms. Something very well regulated and sophisticated enough to fuel the bull run of the decade for ILMN. A merger should be the cherry on top, and maybe the BNGO merger prophecy comes to fruition, but this only time will tell.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.